Clinical Trial Update: A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the Cypher Sirolimus-Eluting Stent for bifurcation lesions in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED